Home
Octagon Capital Advisors reported a 4.7% stake in Unicycive Therapeutics UNCY · 1,000,000 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 4.7%
- Last report
- 5.7% · filed 25/11/14
- Shares held
- 1,000,000 sh
- Class
- Common Stock, $0.001 par value
- Holder
- Octagon Capital Advisors
- Event date
- 25/12/31
- Filed
- 26/02/10
4.7% stake · below 5%
- Stake
- 4.7%
- Last report
- 5.7%
- Since last report
- −1.0pp
Unicycive Therapeutics trades, last 26 weeks
What else happened in Unicycive Therapeutics around then
Filed or reported within 30 days of the trade day · 25/12/01~01/30Octagon Capital Advisors's other 5% stake reports
- Octagon Capital Advisors
5% stakeContext Therapeutics
5% stakeContext Therapeutics
CNTX
3.3% stake
3,050,000 sh
3.3% stake
Filed 07/31
- Octagon Capital Advisors
5% stakeContext Therapeutics
5% stakeContext Therapeutics
CNTX
5.7% stake
5,250,000 sh
5.7% stake
Filed 05/14
- Octagon Capital Advisors
5% stakeCorbus Pharmaceuticals Holdings
5% stakeCorbus Pharmaceuticals Holdings
CRBP
0% stake
0 sh
0% stake
Filed 05/14
- Octagon Capital Advisors
5% stakeGossamer Bio
5% stakeGossamer Bio
GOSS
3.8% stake
8,976,054 sh
3.8% stake
Filed 05/14
- Octagon Capital Advisors
5% stakeDianthus Therapeutics
5% stakeDianthus Therapeutics
DNTH
3.6% stake
1,946,667 sh
3.6% stake
Filed 05/14
